title: Minimally Invasive Breast Augmentation: Where Is the Evidence?
authors.affiliation: The Cadogan Clinic, and Department of Plastic Surgery, Royal Free Hampstead NHS Trust, London, United Kingdom The University of Chicago Medicine, Chicago, Ill. The Cadogan Clinic, and Charing Cross Hospital, London, United Kingdom Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom Wexham Park Hospital, Berkshire, United Kingdom Dallas Plastic Surgery Institute, Dallas, Texas.
authors.forename: Patrick
authors.initials: P
authors.lastname: Mallucci
authors.forename: David H
authors.initials: DH
authors.lastname: Song
authors.forename: Olivier A
authors.initials: OA
authors.lastname: Branford
authors.forename: William A
authors.initials: WA
authors.lastname: Townley
authors.forename: Fulvio
authors.initials: F
authors.lastname: Urso-Baiarda
authors.forename: Rod J
authors.initials: RJ
authors.lastname: Rohrich
mesh_terms: D019274:Botulinum Toxins, Type A / Q000008:administration & dosage* / Q000009:adverse effects; D001940:Breast; D003357:Cosmetic Techniques / Q000009:adverse effects / Q000941:ethics*; D005260:Female; D006801:Humans; D007267:Injections; D016462:Mammaplasty; D012965:Sodium Chloride / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D012965:Sodium Chloride; D019274:Botulinum Toxins, Type A